TY - JOUR
T1 - Decoupling Fluorous Protein Coatings Yield Heat-Stable and Intrinsically Sterile Bioformulations
AU - Singh, Harminder
AU - Lawanprasert, Atip
AU - Utkarsh, None
AU - Pimcharoen, Sopida
AU - Dewan, Arshiya
AU - Rahoi, Dane
AU - Kirimanjeswara, Girish S.
AU - Medina, Scott H.
N1 - Publisher Copyright:
© 2024 The Authors. Published by American Chemical Society.
PY - 2024/7/31
Y1 - 2024/7/31
N2 - Thermal inactivation is a major bottleneck to the scalable production, storage, and transportation of protein-based reagents and therapies. Failures in temperature control both compromise protein bioactivity and increase the risk of microorganismal contamination. Herein, we report the rational design of fluorochemical additives that promiscuously bind to and coat the surfaces of proteins to enable their stable dispersion within fluorous solvents. By replacing traditional aqueous liquids with fluorinated media, this strategy conformationally rigidifies proteins to preserve their structure and function at extreme temperatures (≥90 °C). We show that fluorous protein formulations resist contamination by bacterial, fungal, and viral pathogens, which require aqueous environments for survival, and display equivalent serum bioavailability to standard saline samples in animal models. Importantly, by designing dispersants that decouple from the protein surface in physiologic solutions, we deliver a fluorochemical formulation that does not alter the pharmacologic function or safety profile of the functionalized protein in vivo. As a result, this nonaqueous protein storage paradigm is poised to open technological opportunities in the design of shelf-stable protein reagents and biopharmaceuticals.
AB - Thermal inactivation is a major bottleneck to the scalable production, storage, and transportation of protein-based reagents and therapies. Failures in temperature control both compromise protein bioactivity and increase the risk of microorganismal contamination. Herein, we report the rational design of fluorochemical additives that promiscuously bind to and coat the surfaces of proteins to enable their stable dispersion within fluorous solvents. By replacing traditional aqueous liquids with fluorinated media, this strategy conformationally rigidifies proteins to preserve their structure and function at extreme temperatures (≥90 °C). We show that fluorous protein formulations resist contamination by bacterial, fungal, and viral pathogens, which require aqueous environments for survival, and display equivalent serum bioavailability to standard saline samples in animal models. Importantly, by designing dispersants that decouple from the protein surface in physiologic solutions, we deliver a fluorochemical formulation that does not alter the pharmacologic function or safety profile of the functionalized protein in vivo. As a result, this nonaqueous protein storage paradigm is poised to open technological opportunities in the design of shelf-stable protein reagents and biopharmaceuticals.
UR - http://www.scopus.com/inward/record.url?scp=85199095843&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85199095843&partnerID=8YFLogxK
U2 - 10.1021/acsami.4c03724
DO - 10.1021/acsami.4c03724
M3 - Article
C2 - 39013021
AN - SCOPUS:85199095843
SN - 1944-8244
VL - 16
SP - 38893
EP - 38904
JO - ACS Applied Materials and Interfaces
JF - ACS Applied Materials and Interfaces
IS - 30
ER -